JMJD3 was associated with apoptosis in osteoblast differentiation (75, 76) or stroke (57), however no obviously different pre-caspase3 and Bcl2 expression in GSK-J4 treated M-BMDMs and GM-BMDMs. Here, BCL2 is linked to stroke disorder.